Prestige Consumer Healthcare (PBH) Deferred Taxes (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Deferred Taxes came in at $3.6 million in Q4 2025, up 23.44% year-on-year from $2.9 million in Q4 2024, and down 79.31% quarter-over-quarter from $17.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Deferred Taxes (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Deferred Taxes history runs 16 years deep, the most recent figure standing at $3.6 million for Q4 2025.
- On a quarterly basis, Deferred Taxes rose 23.44% year-over-year to $3.6 million in Q4 2025; TTM through Dec 2025 was $33.9 million, a 119.58% increase from a year earlier, with the FY2025 full-year figure at $14.4 million, down 37.54% from the prior year.
- Deferred Taxes declined to $3.6 million in Q4 2025 per PBH's latest filing, from $17.4 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $17.4 million in Q3 2025 and bottomed at -$74.8 million in Q1 2023.
- The 5-year median for Deferred Taxes is $4.0 million (2023), against an average of $1.2 million.
- Across the five-year window, Deferred Taxes slumped 5578.51% in 2023 and soared 852.12% in 2025, its largest moves.
- Year by year, Deferred Taxes stood at $3.7 million in 2021, then soared by 168.25% to $9.8 million in 2022, then sank by 47.29% to $5.2 million in 2023, then tumbled by 43.65% to $2.9 million in 2024, then grew by 23.44% to $3.6 million in 2025.
- Per Business Quant, the three latest PBH Deferred Taxes figures stand at $3.6 million (Q4 2025), $17.4 million (Q3 2025), and $5.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 17.38 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 7.13 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 612,000.00 |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Sep 30, 2023 | 5.45 Mn |
| Jun 30, 2023 | 4.27 Mn |
| Mar 31, 2023 | -74.79 Mn |
| Dec 31, 2022 | 9.81 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | -1.32 Mn |
| Dec 31, 2021 | 3.66 Mn |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 5.88 Mn |
| Mar 31, 2021 | 10.66 Mn |